Read-across in REACH and its assessment
This record is part of
a dataset collected by the EU Commission in June-September 2018
. Some of these links will therefore die out with time.
Please see the
overview of courses maintained by ETPLAS
or contact Norecopa for more information.
Owner/Developer: Association of European Toxicologists & European Societies of Toxicology (EUROTOX)
| Country: |
Belgium |
|---|---|
| Languages: |
English |
| Url: |
http://www.eurotox-congress.com/2018/_medien/_content/files/180821_Eurotox-2018_Programm_WEB_final(1).pdf |
| Created: |
02 September 2018 |
| Founding source: |
citoxlab, TPL, UCB, Janssen, RTC, Elsevier, DouglasConnect, Knoell, Covance, MatTek, ToxMinds, Umicore, Charles River, Cosmetics Europe, Solvay, Envigo, Sysmex, OECD, EPAA, Cabot, Ecetoc, SOT, Hesi, FNRS, Team Mastery, Marshall, Ablynx |
| Locations: |
Belgium |
| City: |
Brussels |
| Description: | Read-across is an important scientific method for providing reliable information on the properties of substances, whilst minimising the use of animals. It is widely used in a variety of legislations, and this session seeks to develop overarching approaches to improved read-across in general, by focusing on the specific example of its use in REACH. The session starts by describing the nature of read-across in REACH, the extent of the use of read-across in REACH registration dossiers, and the use of the recently developed read-across assessment framework to evaluate read-across in a consistent way. Scientific challenges associated with the use of read-across for multi-constituent substances, and substances of Unknown or Variable composition, Complex reaction products or Biological materials (UVCBs) are mapped out. Novel and alternative methods can support the use of read-across, and novel frameworks for considering how this information can be applied to read-across will be discussed. The challenges of dealing with read-across for a variety of industrial chemicals will be discussed, making reference to uncertainty in the regulatory landscape and other challenges for successful read-across. The session aims to summarise key concepts for sucessful application of read-across in a variety of regulatory settings. |
| References: | go to page 39 of the provided link |
| Format: |
Lecture |
| Presence: |
Optional / Voluntary |
| Access: |
Fee-based |
| Content type: |
Theoretical |
| Duration: |
1 day |
| Frequency: |
Recurrent event |
| Target audience: |
Professionals (e.g. veterinarians), Scientific officers / Project managers, Managers, Technicians, Teachers and educators, Regulators and policy-makers, Researchers |
| Target sectors: |
SMEs, Consulting, Contract Research Organizations (CROs), Governmental bodies, Industry, Academia |
| Educational level: |
Continuing Professional Development |
| 3rs relevance: |
Replacement |
| Topics covered: |
Computational methods |
| 3rs coverage: |
Full coverage (a dedicated course) |
| Details on the topic or technology covered: |
1. Read-across in REACH and the read-across assessment framework (RAAF) 2. Scientific considerations for assessing read-across between multiconstituent or UVCB substances 3. Scientific Issues That Need to be Addressed for a Successful Read-Across Prediction 4. Quantitative assessment of mitochondrial toxicity and downstream cellular perturbations in Adverse Outcome Pathways. 5. Key issues for successful read-across - a user’s guide |
| Legislative framework: |
REACH Regulation (EC) No 1907/2006 or equivalent |
| Accreditation body and/or authority that approved the education or training: |
Eurotox Education Program |
| Qualification received: |
certificate of attendance |
Fant du det du lette etter?
Ja, jeg fant det! Nei, jeg fant det ikke!Takk for din tilbakemelding! Vær oppmerksom på at vi ikke kan kontakte deg hvis ikke du oppgir din epostadresse.
Hva lette du etter?
Gi oss gjerne en tilbakemelding slik at vi kan forbedre informasjonen på siden. På forhånd takk for hjelpen! Vennligst skriv inn din epostadresse hvis du vil ha et svar.
Kontakt oss gjerne på e-post hvis du har spørsmål.